6649 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Taiwan Biomaterial Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical equipment. It produces foamagen, stroke interventional treatment devices, early degenerative arthritis tissue repair and regeneration products. The company was founded by Hsiao Hsiung Ko, Chun Jen Liao and Wen Hsi Wang on November 12, 2012 and is headquartered in Zhubei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
6649 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company